Evidence map›Paper›PMID 37629044›Full record

ArticleInternational journal of molecular sciences2023

Bruna C Bertol, Guilherme Debortoli, Fabrício C Dias, Jéssica N G de Araújo, Luana S M Maia, Bibiana S de Almeida, Nathalie L de Figueiredo-Feitosa, Luiz Carlos C de Freitas, Erick C Castelli, Celso T Mendes-Junior and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Bruna C BertolPostgraduate Program of Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-9301-449X
Guilherme DebortoliDepartment of Anthropology, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.
Fabrício C DiasDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Jéssica N G de AraújoDepartment of Clinical Analysis and Toxicology, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.
Luana S M MaiaDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Bibiana S de AlmeidaDivision of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Nathalie L de Figueiredo-FeitosaDivision of Endocrinology and Metabolism, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Luiz Carlos C de FreitasDepartment of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-2153-6512
Erick C CastelliDepartment of Pathology, School of Medicine, São Paulo State University, Botucatu 18618-687, Brazil.
Celso T Mendes-JuniorDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14049-900, Brazil.ORCID 0000-0002-7337-1203
Vivian N SilbigerDepartment of Clinical Analysis and Toxicology, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.ORCID 0000-0002-9252-0278
Léa M Z MacielDivision of Endocrinology and Metabolism, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Eduardo A DonadiPostgraduate Program of Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil.
Universidade de São Paulo · BRUniversidade Federal do Rio Grande do Norte · BRUniversidade de Ribeirão Preto · BRUniversidade Estadual Paulista (Unesp) · BRUniversity Health Network · CAUniversity of Toronto · CA

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior #071/2013National Council for Scientific and Technological Development #457231/2013 and #302060/2019-7Programa Nacional de Cooperação Acadêmica (PROCAD) #88881-068436/2014-1São Paulo Research Foundation #2015/26556-0
6 · The paper itself

Abstract

Human leukocyte antigen (HLA)-G is an immune checkpoint molecule that is highly expressed in papillary thyroid carcinoma (PTC). The

Indexed as

HLA-G AntigensThyroid Neoplasms3' Untranslated RegionsGTP-Binding ProteinsHumansMorbidityThyroid Cancer, Papillary3' Untranslated RegionsGTP-Binding ProteinsHLA-G AntigenshaplotypesHLA-Gpapillary thyroid carcinoma

Identifiers

PMID37629044
PMCPMC10454351
OpenAlexW4385873581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.